Clinical trial Recruiting at 12 sites Interventional Ages 22 and up Women only

Investigation of Acellular Dermal Matrix in Breast Reconstruction

Official title: Acellular Dermal Matrix Investigation in Breast Reconstruction

Run by RTI Surgical · NCT06456554 · Data updated 2026-11-12

This study is testing if using a special tissue matrix can improve results for women having breast reconstruction surgery with a new technique.

More Breast Reconstruction trials

Quick facts

Study typeInterventional
Ages22 Years and up
SexWomen only
Enrollment467 (estimated)
SponsorRTI Surgical
Industry-sponsored
Locations13 sites (Little Rock, Arkansas and 12 other locations)
StatusRecruiting
StartedNovember 22, 2024
Main results expectedDecember 2026
Study endsDecember 2027
Registry record updatedApril 30, 2026
Trial IDNCT06456554 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are genetic females aged 22 or older who are undergoing immediate breast reconstruction with a two-stage pre-pectoral technique.

Probably not a fit

Patients who are pregnant, breastfeeding, or have serious pre-existing medical conditions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial is a prospective, multi-center, dual-arm non-randomized study focusing on females undergoing a two-stage breast reconstruction using a pre-pectoral technique. Participants will receive an acellular dermal matrix treatment to evaluate its effectiveness in this surgical approach. The study aims to gather data on the outcomes of using Cortiva Tissue Matrix in breast reconstruction procedures. The trial will involve multiple locations to ensure a diverse participant pool.

Why it matters

Potential benefit: If successful, this study could improve surgical outcomes and recovery for women undergoing breast reconstruction.

How similar studies have gone: Other studies have explored the use of acellular dermal matrices in breast reconstruction, showing promising results, but this specific approach may offer novel insights.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Genetic female
* Age 22 or older at time of consent
* Undergoing immediate breast reconstruction
* 2 stage breast reconstruction using pre pectoral technique
* Nipple or skin sparing mastectomy
* Willing and capable of providing informed consent
* Able to comply with study requirements

Exclusion Criteria:

* Planned concurrent reconstruction with pedicled flaps or free tissue
* Pregnant or breast feeding
* Investigator has determined tissue is unsuitable for two-stage breast reconstruction
* History of psychological characteristics that may be incompatible with the surgical procedure and the prosthesis
* Any serious and/or unstable pre-existing medical disorder or other conditions that could interfere with the subject's safety, the informed consent process, or compliance with the study protocol, in the opinion of the investigator
* Vulnerable subject populations
* Currently participating in another clinical trial that would have the potential to interfere or conflict with the treatment, follow-up, or objectives of this study
* Prior history of neoadjuvant radiotherapy to the reconstruction site or chest wall
* Active abscess or infection in the intended reconstruction site
* Residual gross tumor at the intended reconstruction site
* Active use of any tobacco/nicotine products
* Has body mass index (BMI) \>35
* Uncontrolled diabetes defined as HbA1c ≥7 within 3 months prior to stage 1 procedure
* Is currently taking medications including systemic steroids

Where it's running

  • University of Arkansas
    Little Rock, Arkansas, United States
    Recruiting
  • City of Hope National Medical Center
    Duarte, California, United States
    Recruiting
  • University of Colorado
    Aurora, Colorado, United States
    Recruiting
  • University of Kansas
    Lawrence, Kansas, United States
    Recruiting
  • Washington University
    St Louis, Missouri, United States
    Recruiting
  • Mercy Hospital
    St Louis, Missouri, United States
    Recruiting
Show 7 more locations
  • NYU Langone Health
    New York, New York, United States
    Recruiting
  • New York Presbyterian Hospital/Columbia University Irving Medical Center
    New York, New York, United States
    Recruiting
  • Cleveland Clinic
    Cleveland, Ohio, United States
    Recruiting
  • Mercy
    Oklahoma City, Oklahoma, United States
    Recruiting
  • University of Pennsylvania
    Philadelphia, Pennsylvania, United States
    Recruiting
  • MD Anderson
    Houston, Texas, United States
    Recruiting
  • Mercy Hospital
    Oklahoma City, Oklahoma, United States
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.